Thrombosis diagnostic evaluation

Thrombosis Microchapters
Home
Patient Information
Overview
Pathophysiology
Classification
Arterial
Venous
Arterial and Venous Thrombosis: Differences and Similarities
Causes
Site of Thrombosis
Arterial
Venous
Differentiating Thrombosis from other Diseases
Arterial
Venous
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Evaluation
Treatment
Risk Factor Modifications
Prevention
Thrombosis diagnostic evaluation On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thrombosis diagnostic evaluation
CDC onThrombosis diagnostic evaluation
Thrombosis diagnostic evaluation in the news
Blogs on Thrombosis diagnostic evaluation
to Hospitals Treating Thrombosis diagnostic evaluation
Risk calculators and risk factors for Thrombosis diagnostic evaluation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]

DiagnoStic Evaluation

cDNA-PCR assays for gene mutations and polymorphisms:

• 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene (PAI-1)
• Cystathionine beta synthetase (CBS) CBS T833C & G919A
• Factor V Leiden
• Glycoprotein IIIa A1/A2 (platelet glycoprotein)
• Methylenetetrahydrofolate reductase (MTHFR) MTHFR C677T
• Prothrombin G20210A

Serologic (blood) tests:

• Anticardiolipin antibodies (ACLA) IgG and IgM ACLA
• Antithrombin III
• Factor VIII
• Homocysteine
• Lupus anticoagulant (LA)
• Proteins C
• Protein S

Evaluation of hypofibrinolysis

• 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene (PAI-1)(requires cDNA-PCR assay for gene mutation)
• Lipoprotein a Lp(a)